Central Role of IL-6 Receptor Signal-Transducing Chain gp130 in Activation of L-Selectin Adhesion by Fever-Range Thermal Stress

Immunity

Volumn 20, Issue 1, 2004, Pages 59-70

  Chen, Qing ^a   Wang, Wan Chao ^a   Bruce, Robert ^a   Li, Hong ^a   Schleider, David M ^a   Mulbury, Michael J ^a   Bain, Mark D ^a   Wallace, Paul K ^a   Baumann, Heinz ^a   Evans, Sharon S ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYTOSKELETON PROTEIN; GLYCOPROTEIN GP 130; HOMING RECEPTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 11; INTERLEUKIN 6; L SELECTIN; LEUKEMIA INHIBITORY FACTOR; M PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; ONCOSTATIN M; PROTEIN SUBUNIT; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ADHESION; CYTOKINE RELEASE; FEVER; HEAT STRESS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 9144220760     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00358-3     Document Type: Article

References (48)

1. Aarden L.A., De Groot E.R., Schaap O.L., Lansdorp P.M. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 17:1987;1411-1416.
2. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
3. Atreya R., Mudter J., Finotto S., Mullberg J., Jostock T., Wirtz S., Schutz M., Bartsch B., Holtmann M., Becker C.et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation. evidence in Crohn disease and experimental colitis in vivo Nat. Med. 6:2000;583-588.
4. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y.et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA. 98:2001;13681-13686.
5. Butcher E.C., Williams M., Youngman K., Rott L., Briskin M. Lymphocyte trafficking and regional immunity. Adv. Immunol. 72:1999;209-253.
6. Chen Y., Alm K., Vujcic S., Kramer D.L., Kee K., Diegelman P., Porter C.W. The role of mitogen-activated protein kinase activation in determining cellular outcomes in polyamine analogue-treated human melanoma cells. Cancer Res. 63:2003;3619-3625.
7. Cressman D.E., Greenbaum L.E., DeAngelis R.A., Ciliberto G., Furth E.E., Poli V., Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 274:1996;1379-1383.
8. Dean J.L., Brook M., Clark A.R., Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274:1999;264-269.
9. Evans S.S., Collea R.P., Appenheimer M.M., Gollnick S.O. Interferon-alpha induces the expression of the L-selectin homing receptor in human B lymphoid cells. J. Cell Biol. 123:1993;1889-1898.
10. Evans S.S., Schleider D.M., Bowman L.A., Francis M.L., Kansas G.S., Black J.D. Dynamic association of L-selectin with the lymphocyte cytoskeletal matrix. J. Immunol. 162:1999;3615-3624.
11. Evans S.S., Bain M.D., Wang W.C. Fever-range hyperthermia stimulates alpha4beta7 integrin-dependent lymphocyte-endothelial adhesion. Int. J. Hyperthermia. 16:2000;45-59.
12. Evans S.S., Wang W.C., Bain M.D., Burd R., Ostberg J.R., Repasky E.A. Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood. 97:2001;2727-2733.
13. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F.et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:1998;18623-18632.
14. Frey M., Packianathan N.B., Fehniger T.A., Ross M.E., Wang W.C., Stewart C.C., Caligiuri M.A., Evans S.S. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J. Immunol. 161:1998;400-408.
15. Fukada T., Hibi M., Yamanaka Y., Takahashi-Tezuka M., Fujitani Y., Yamaguchi T., Nakajima K., Hirano T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130. involvement of STAT3 in anti-apoptosis Immunity. 5:1996;449-460.
16. Gallucci R.M., Simeonova P.P., Matheson J.M., Kommineni C., Guriel J.L., Sugawara T., Luster M.I. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J. 14:2000;2525-2531.
17. Giancotti F.G., Ruoslahti E. Integrin signaling. Science. 285:1999;1028-1032.
18. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374:2003;1-20.
19. Hibi M., Murakami M., Saito M., Hirano T., Taga T., Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 63:1990;1149-1157.
20. Hirano T. Molecular basis underlying functional pleiotropy of cytokines and growth factors. Biochem. Biophys. Res. Commun. 260:1999;303-308.
21. Hurst S.M., Wilkinson T.S., McLoughlin R.M., Jones S., Horiuchi S., Yamamoto N., Rose-John S., Fuller G.M., Topley N., Jones S.A. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. 14:2001;705-714.
22. Jones S.A., Rose-John S. The role of soluble receptors in cytokine biology. the agonistic properties of the sIL-6R/IL-6 complex Biochim. Biophys. Acta. 1592:2002;251-263.
23. Jostock T., Mullberg J., Ozbek S., Atreya R., Blinn G., Voltz N., Fischer M., Neurath M.F., Rose-John S. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 268:2001;160-167.
24. Kim H., Baumann H. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells. Mol. Cell. Biol. 19:1999;5326-5338.
25. Kishimoto T.K., Jutila M.A., Butcher E.C. Identification of a human peripheral lymph node homing receptor. a rapidly down-regulated adhesion molecule Proc. Natl. Acad. Sci. USA. 87:1990;2244-2248.
26. Kluger M.J., Kozak W., Conn C.A., Leon L.R., Soszynski D. Role of fever in disease. Ann. NY Acad. Sci. 856:1998;224-233.
27. Leid J.G., Steeber D.A., Tedder T.F., Jutila M.A. Antibody binding to a conformation-dependent epitope induces L-selectin association with the detergent-resistant cytoskeleton. J. Immunol. 166:2001;4899-4907.
28. Leon L.R. Invited review. cytokine regulation of fever; studies using gene knockout mice J. Appl. Physiol. 92:2002;2648-2655.
29. Modur V., Li Y., Zimmerman G.A., Prescott S.M., McIntyre T.M. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J. Clin. Invest. 100:1997;2752-2756.
30. Muller-Newen G., Kuster A., Hemmann U., Keul R., Horsten U., Martens A., Graeve L., Wijdenes J., Heinrich P.C. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. J. Immunol. 161:1998;6347-6355.
31. Narazaki M., Yasukawa K., Saito T., Ohsugi Y., Fukui H., Koishihara Y., Yancopoulos G.D., Taga T., Kishimoto T. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood. 82:1993;1120-1126.
32. Ndubuisi M.I., Patel K., Rayanade R.J., Mittelman A., May L.T., Sehgal P.B. Distinct classes of chaperoned IL-6 in human blood. differential immunological and biological availability J. Immunol. 160:1998;494-501.
33. Palframan R.T., Jung S., Cheng G., Weninger W., Luo Y., Dorf M., Littman D.R., Rollins B.J., Zweerink H., Rot A., von Andrian U.H. Inflammatory chemokine transport and presentation in HEV. a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues J. Exp. Med. 194:2001;1361-1373.
34. Pavalko F.M., Walker D.M., Graham L., Goheen M., Doerschuk C.M., Kansas G.S. The cytoplasmic domain of L-selectin interacts with cytoskeletal proteins via alpha-actinin. receptor positioning in microvilli does not require interaction with alpha-actinin J. Cell Biol. 129:1995;1155-1164.
35. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., Faggioni R., Luini W., van Hinsbergh V., Sozzani S.et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 6:1997;315-325.
36. Sallusto F., Mackay C.R., Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18:2000;593-620.
37. Schulte T.W., Blagosklonny M.V., Ingui C., Neckers L. Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association. J. Biol. Chem. 270:1995;24585-24588.
38. Sehgal P.B. Interleukin-6-type cytokines in vivo. regulated bioavailability Proc. Soc. Exp. Biol. Med. 213:1996;238-247.
39. Shah A., Unger E., Bain M.D., Bruce R., Bodkin J., Ginnetti J., Wang W.C., Seon B., Stewart C.C., Evans S.S. Cytokine and adhesion molecule expression in primary human endothelial cells stimulated with fever-range hyperthermia. Int. J. Hyperthermia. 18:2002;534-551. a.
40. Shah M., Patel K., Fried V.A., Sehgal P.B. Interactions of STAT3 with caveolin-1 and heat shock protein 90 in plasma membrane raft and cytosolic complexes. Preservation of cytokine signaling during fever. J. Biol. Chem. 277:2002;45662-45669. b.
41. Simpson G. The nature and origin of supraspecific taxa. Cold Spring Harb. Symp. Quant. Biol. 24:1959;255-271.
42. Stewart, C.C., and Stewart, S.J. (2001). Cell Preparation for the Identification of Leukocytes, Volume 63 (New York: Academic Press, Inc,).
43. Swartz K.R., Liu F., Sewell D., Schochet T., Campbell I., Sandor M., Fabry Z. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res. 896:2001;86-95.
44. Wang W.C., Goldman L.M., Schleider D.M., Appenheimer M.M., Subjeck J.R., Repasky E.A., Evans S.S. Fever-range hyperthermia enhances L-selectin-dependent adhesion of lymphocytes to vascular endothelium. J. Immunol. 160:1998;961-969.
45. Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X.F., Achong M.K. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101:1998;311-320.
46. Xu F.H., Sharma S., Gardner A., Tu Y., Raitano A., Sawyers C., Lichtenstein A. Interleukin-6-induced inhibition of multiple myeloma cell apoptosis. support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway Blood. 92:1998;241-251.
47. Yujiri T., Sather S., Fanger G.R., Johnson G.L. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science. 282:1998;1911-1914.
48. Zauberman A., Zipori D., Krupsky M., Ben-Levy R. Stress activated protein kinase p38 is involved in IL-6 induced transcriptional activation of STAT3. Oncogene. 18:1999;3886-3893.